The American Thoracic Society, U.S. Centers for Disease Control and Prevention, European Respiratory Society, and Infectious Diseases Society of America jointly sponsored this new practice guideline on the treatment of drug-resistant tuberculosis (DR-TB). The document includes recommendations on the treatment of multidrug-resistant TB (MDR-TB) as well as isoniazid-resistant but rifampin-susceptible TB.
Audiences:
Health Professionals
Focus Area:
TB
Subjects:
Treatment- TB Disease
Publication Date:
2019
Format:
Guideline
Last Updated Date:
Publication ID:
365084